Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 120

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 6
Chunk 120
---

and Phillip Hains loaned A$2.2 million to Radiopharm to support its operations prior to the launch of a capital raise in June 2024. The
loans were fully repaid in June 2024.

In fiscal 2025, the Acclime
Group invoiced Radiopharm for professional services such as financial reporting, capital management, company secretarial, accounting,
bookkeeping, and payroll activities, amounting to A$415,909. Mr. Hains, a Director of Acclime Australia, is Radiopharm’s Chief Financial
Officer as well as a Director.

C. Interests of Experts and Counsel

Not applicable.

Item 8. Financial Information